Yesterday, the U.S. Food and Drug Administration (FDA) approved the first drug in the country that has a digital tracking system that you can swallow. It’s a prescription medication called Abilify MyCite. The “GPS” is attached to an aripiprazole tablet which treats schizophrenia, bipolar disorder, depression, and Tourette syndrome. It is also used to calm those with autism.
Patients would download an app that keeps track of the pills ingestion process. The pill sends information to a patch that you wear, and that information is then read by the app. The information can be accessed by patients, doctors or caretakers online. The goal is to make sure patients are consistently taking medication and that the medication is functioning properly.